These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1708145

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure.
    Preston KL, Bigelow GE.
    J Pharmacol Exp Ther; 1994 Oct; 271(1):48-60. PubMed ID: 7525929
    [Abstract] [Full Text] [Related]

  • 3. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE, Bigelow GE, Preston KL.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [Abstract] [Full Text] [Related]

  • 4. Drug discrimination in human postaddicts: agonist-antagonist opioids.
    Preston KL, Bigelow GE, Bickel WK, Liebson IA.
    J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187
    [Abstract] [Full Text] [Related]

  • 5. Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure.
    Oliveto A, Sevarino K, McCance-Katz E, Feingold A.
    Pharmacol Biochem Behav; 2002 Jul; 71(1-2):85-96. PubMed ID: 11812511
    [Abstract] [Full Text] [Related]

  • 6. Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline.
    Preston KL, Bigelow GE, Bickel W, Liebson IA.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1002-9. PubMed ID: 2447262
    [Abstract] [Full Text] [Related]

  • 7. Antagonist effects of nalbuphine in opioid-dependent human volunteers.
    Preston KL, Bigelow GE, Liebson IA.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):929-37. PubMed ID: 2467983
    [Abstract] [Full Text] [Related]

  • 8. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
    Preston KL, Bigelow GE, Liebson IA.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):441-8. PubMed ID: 2457074
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination.
    Preston KL, Liebson IA, Bigelow GE.
    J Pharmacol Exp Ther; 1992 Apr; 261(1):62-71. PubMed ID: 1373189
    [Abstract] [Full Text] [Related]

  • 11. Three-choice discrimination in pigeons is based on relative efficacy differences among opioids.
    Walker EA, Picker MJ, Dykstra LA.
    Psychopharmacology (Berl); 2001 Jun; 155(4):389-96. PubMed ID: 11441428
    [Abstract] [Full Text] [Related]

  • 12. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ, Benyas S, Horwitz JA, Thompson K, Mathewson C, Smith MA.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [Abstract] [Full Text] [Related]

  • 13. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy.
    Negus SS, Mello NK.
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1111-21. PubMed ID: 11861822
    [Abstract] [Full Text] [Related]

  • 14. Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination.
    Preston KL, Bigelow GE.
    J Pharmacol Exp Ther; 2000 Oct; 295(1):114-24. PubMed ID: 10991968
    [Abstract] [Full Text] [Related]

  • 15. Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
    Dykstra LA.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):245-52. PubMed ID: 2164093
    [Abstract] [Full Text] [Related]

  • 16. Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons: importance of training dose and attenuation by the D3 agonist (+/-)-7-OH-DPAT.
    Cook CD, Picker MJ.
    Psychopharmacology (Berl); 1998 Mar; 136(1):59-69. PubMed ID: 9537683
    [Abstract] [Full Text] [Related]

  • 17. Assessment of buprenorphine in a drug discrimination procedure in humans.
    Bigelow GE, Preston KL.
    NIDA Res Monogr; 1992 Mar; 121():28-37. PubMed ID: 1406908
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of nalbuphine and butorphanol treatment on cocaine and food self-administration by rhesus monkeys.
    Mello NK, Kamien JB, Lukas SE, Drieze J, Mendelson JH.
    Neuropsychopharmacology; 1993 Jan; 8(1):45-55. PubMed ID: 8381011
    [Abstract] [Full Text] [Related]

  • 20. Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers.
    Strain EC, Preston KL, Liebson IA, Bigelow GE.
    J Pharmacol Exp Ther; 1992 Jun; 261(3):985-93. PubMed ID: 1376362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.